Literature DB >> 15911350

Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death.

Kyoko Tsuboi1, John J Grzesiak, Michael Bouvet, Makoto Hashimoto, Eliezer Masliah, Clifford W Shults.   

Abstract

The cardinal pathological features of multiple system atrophy (MSA) are the presence of glial cytoplasmic inclusions (GCIs) in oligodendrocytes and loss of oligodendrocytes. To understand the mechanisms underlying MSA, we examined the effects of overexpression of human alpha-synuclein (halpha-syn) in CG-4 oligodendrocytic progenitor cells. CG-4 cells overexpressing halpha-syn (halpha-syn CG-4) demonstrated severely impaired adhesion and increased cell death when plated on fibronectin compared to laminin. The expression of the alphav integrin subunit in whole cell lysates was also significantly downregulated in halpha-syn CG-4. These results demonstrate a cytotoxic consequence of halpha-syn overexpression in CG-4. This cytotoxicity appears to be the result of alterations in cell-extracellular matrix interactions, where impaired adhesion to fibronectin is associated with downregulation of the alphav integrin subunit and increased cell death. It may, therefore, be one of the mechanisms underlying the loss of oligodendrocytes in MSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911350     DOI: 10.1016/j.mcn.2005.03.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  15 in total

1.  Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.

Authors:  Taeyeon Kim; Elvira Valera; Paula Desplats
Journal:  Mol Neurobiol       Date:  2019-04-09       Impact factor: 5.590

2.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

Review 3.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 4.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

5.  Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular α-synuclein in oligodendrocytes.

Authors:  Katharina Pukass; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

6.  Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells.

Authors:  Benjamin Ettle; Simone Reiprich; Janina Deusser; Johannes C M Schlachetzki; Wei Xiang; Iryna Prots; Eliezer Masliah; Beate Winner; Michael Wegner; Jürgen Winkler
Journal:  Mol Cell Neurosci       Date:  2014-07-11       Impact factor: 4.314

7.  {alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics.

Authors:  Vítor L Sousa; Serena Bellani; Maila Giannandrea; Malikmohamed Yousuf; Flavia Valtorta; Jacopo Meldolesi; Evelina Chieregatti
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

Review 8.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.

Authors:  Lisa Fellner; Kurt A Jellinger; Gregor K Wenning; Nadia Stefanova
Journal:  Acta Neuropathol       Date:  2011-05-12       Impact factor: 17.088

Review 9.  Glia and alpha-synuclein in neurodegeneration: A complex interaction.

Authors:  Dominik Brück; Gregor K Wenning; Nadia Stefanova; Lisa Fellner
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

Review 10.  The role of glia in α-synucleinopathies.

Authors:  Lisa Fellner; Nadia Stefanova
Journal:  Mol Neurobiol       Date:  2012-09-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.